Daniel J. Lindner, MD, PhD

Assistant Professor
Department of Molecular Medicine
School of Medicine
Developmental Therapeutics Program
Case Comprehensive Cancer Center

Research Information

Research Projects

Dr. Lindner’s research involves the study of mechanisms of acquired drug resistance in renal cancer, and development of more effective drugs to treat myelodysplastic syndrome and acute myelogenous leukemia.  His research in the Athymic Animal & Xenograft Core Facility at CWRU deals with utilizing human and mouse tumor models, angiogenesis (growth of blood vessels stimulated by tumors) and pharmacokinetics (the movement and metabolism of drugs in the body). Animal experiments are routinely conducted in the Athymic Animal & Xenograft Core, including research on mouse and human tumor models.

External Appointments

Associate Staff, Center for Hematology and Oncology Molecular Therapeutics
Taussig Cancer Institute, Cleveland Clinic
Associate Staff, Department of Cancer Biology
Lerner Research Institute, Cleveland Clinic


Additional Information